Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yamashita Health Care Holdings (TSE:9265) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Yamashita Health Care Holdings EBITDA Margin % Related Terms
Yamashita Health Care Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings EBITDA Margin % Chart
TSE:9265 vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Yamashita Health Care Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yamashita Health Care Holdings EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Yamashita Health Care Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings (TSE:9265) has a EBITDA Margin % of 1.57% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Yamashita Health Care Holdings and its competitors. This is 11% below median its historical median of 1.76. Over the past decade, Yamashita Health Care Holdings' EBITDA Margin % has ranged from 0.97 to 2.26. According to the industry distribution chart, Yamashita Health Care Holdings ranks #88 out of 118 companies in the Medical Distribution industry, placing it in the top 74.6%.
Is Yamashita Health Care Holdings' EBITDA Margin % too high?
Yamashita Health Care Holdings' current EBITDA Margin % of 1.57% is 11% below median its 10-year median of 1.76. Over the past 10 years, this metric has ranged from a low of 0.97 to a high of 2.26. The Medical Distribution industry median EBITDA Margin % is 4.16. Yamashita Health Care Holdings' value of 1.57% is 62.2% below this industry median. Based on the distribution chart, Yamashita Health Care Holdings ranks #88 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Yamashita Health Care Holdings has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' EBITDA Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Yamashita Health Care Holdings ranks #88 out of 118 companies for EBITDA Margin %. This places Yamashita Health Care Holdings in the lower half of its industry. The industry median EBITDA Margin % is 4.16. Yamashita Health Care Holdings' value of 1.57% is 62.2% below this benchmark. Historically, Yamashita Health Care Holdings' own EBITDA Margin % has ranged from 0.97 to 2.26 over the past decade. While the company's 10-year median is 1.76 vs. the industry median of 4.16, Yamashita Health Care Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.16, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yamashita Health Care Holdings's current EBITDA Margin % of 1.57% is 62.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Yamashita Health Care Holdings and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yamashita Health Care Holdings's current EBITDA Margin % is 1.57%, which is 11% below median its own 10-year median of 1.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,955.01, compared to a current price of 円3,395.00 — trading 14.9% above its estimated fair value. The current EBITDA Margin % is 1.57%, which is 11% below median its 10-year median of 1.76 and 62.2% below the Medical Distribution industry median of 4.16. Yamashita Health Care Holdings' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current EBITDA Margin % is 1.57% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,395.00 is trading 14.9% above its estimated GF Value™ of 円2,955.01.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
EBITDA Margin %: 1.57% (11% below median its 10-year median of 1.76)
GF Value™: 円2,955.01 vs. price of 円3,395.00 (14.9% above fair value)
Industry Position: 62.2% below the Medical Distribution median (#88 of 118)
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
64GF Score
Get the complete analysis for TSE:9265
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
